Tecadenoson (CVT-510) is a novel and potent adenosine A1 receptor agonist (ADORA1) with the potential to be used for the treatment of paroxysmal supraventricular tachycardia. Tecadenoson appears to be an effective agent for producing rapid and sustained conversion of PSVT to sinus rhythm.